Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Assembly Biosciences (ASMB)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 353,073
  • Shares Outstanding, K 17,350
  • Annual Sales, $ 0 K
  • Annual Income, $ -44,260 K
  • 36-Month Beta 0.35
  • Price/Sales 519.23
  • Price/Cash Flow N/A
  • Price/Book 5.32

Price Performance

See More
Period Period Low Period High Performance
1-Month
20.01 +6.35%
on 06/26/17
28.24 -24.65%
on 05/30/17
-4.42 (-17.20%)
since 05/26/17
3-Month
20.01 +6.35%
on 06/26/17
28.24 -24.65%
on 05/30/17
-4.72 (-18.15%)
since 03/28/17
52-Week
5.15 +313.20%
on 08/02/16
28.24 -24.65%
on 05/30/17
+15.84 (+291.18%)
since 06/28/16

Most Recent Stories

More News
Assembly Biosciences Announces June Conference Presentations

Assembly Biosciences, Inc. (NASDAQ:ASMB), a clinical-stage biotechnology company advancing a new class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel oral live biotherapeutics...

ASMB : 21.28 (+4.57%)
Assembly Biosciences Announces the Closing and Early Termination of Hart-Scott-Rodino Waiting Period for License of Microbiome Gastrointestinal Development Programs to Allergan

Assembly Biosciences, Inc. (NASDAQ:ASMB), a clinical-stage biotechnology company advancing a new class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel oral live biotherapeutics...

AGN : 246.71 (+0.25%)
ASMB : 21.28 (+4.57%)
Assembly Biosciences Announces Successful Completion of ABI-H0731 Phase 1a Trial and Upcoming Conference Presentations

Assembly Biosciences, Inc. (NASDAQ:ASMB), a clinical-stage biotechnology company advancing a new class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel oral live biotherapeutics...

ASMB : 21.28 (+4.57%)
Assembly Biosciences (ASMB) Looks Good: Stock Up 13.9%

Assembly Biosciences, Inc. (ASMB) was a big mover last session, as the company saw its shares rise nearly 14% on the day.

IPXL : 16.20 (+1.57%)
ASMB : 21.28 (+4.57%)
Allergan Enters Into Licensing Agreement with Assembly Biosciences to Obtain Worldwide Rights to Microbiome Gastrointestinal Development Programs

Allergan plc (NYSE: AGN) and Assembly Biosciences, Inc. (NASDAQ: ASMB) today announced that Allergan has entered into a research, development, collaboration and license agreement for the worldwide rights...

AGN : 246.71 (+0.25%)
ASMB : 21.28 (+4.57%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators mostly agree with the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More

Business Summary

Assembly Biosciences, Inc. is a biopharmaceutical company. It develops therapies for infectious diseases and other disorders of the gastrointestinal (GI) system. Assembly's product portfolio consists of two late stage assets: VEN 307 for relief from pain associated with anal fissures and VEN 308 for...

See More

Support & Resistance

2nd Resistance Point 22.41
1st Resistance Point 21.85
Last Price 21.28
1st Support Level 20.46
2nd Support Level 19.63

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.